Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Work In Process (2016 - 2025)

Historic Work In Process for Collegium Pharmaceutical (COLL) over the last 10 years, with Q3 2025 value amounting to $11.6 million.

  • Collegium Pharmaceutical's Work In Process fell 3312.44% to $11.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.6 million, marking a year-over-year decrease of 3312.44%. This contributed to the annual value of $13.2 million for FY2024, which is 9529.67% up from last year.
  • According to the latest figures from Q3 2025, Collegium Pharmaceutical's Work In Process is $11.6 million, which was down 3312.44% from $12.1 million recorded in Q2 2025.
  • In the past 5 years, Collegium Pharmaceutical's Work In Process ranged from a high of $46.4 million in Q2 2022 and a low of $802000.0 during Q1 2021
  • In the last 5 years, Collegium Pharmaceutical's Work In Process had a median value of $11.6 million in 2025 and averaged $14.1 million.
  • Per our database at Business Quant, Collegium Pharmaceutical's Work In Process soared by 425249.38% in 2022 and then crashed by 8391.67% in 2023.
  • Collegium Pharmaceutical's Work In Process (Quarter) stood at $1.0 million in 2021, then surged by 2350.05% to $24.7 million in 2022, then tumbled by 72.68% to $6.7 million in 2023, then skyrocketed by 95.3% to $13.2 million in 2024, then decreased by 11.65% to $11.6 million in 2025.
  • Its Work In Process stands at $11.6 million for Q3 2025, versus $12.1 million for Q2 2025 and $11.6 million for Q1 2025.